MLSS (Milestone Scientific) Policyholder Funds

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MLSS Milestone Scientific Inc MLSS
37 GF Score
Price $0.50
GF Value $0.60
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Milestone Scientific Policyholder Funds?

Policyholder Funds only applies to insurance companies.

MLSS
37GF Score
Milestone Scientific Inc MLSS
Policyholder Funds is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Milestone Scientific (MLSS) Overvalued in 2026?

Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued. The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60. GuruFocus considers Milestone Scientific to be Modestly Undervalued.

Key valuation signals for MLSS:

  • Policyholder Funds:
  • GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Milestone Scientific Business Description

Address 425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score

Get the complete analysis for MLSS

Policyholder Funds is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.50
Price
$0.60
GF Value